Parent-of-origin specific linkage and association of the IGF2 gene region with birth weight and adult metabolic risk factors

International Journal of Obesity

Volumn 33, Issue 9, 2009, Pages 962-970

  Souren, N Y ^a,b,c   Paulussen, A D C ^b,d   Steyls, A ^b,d   Loos, R J F ^e,f   Brandao, R D ^d   Gielen, M ^a,b,c   Smeets, H J M ^a,d   Beunen, G ^f   Fagard, R ^g   Derom, C ^f   Vlietinck, R ^f   Geraedts, J P ^d   Zeegers, M P ^a,b,c  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b MAASTRICHT UNIVERSITY   (Netherlands)

^c UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^d MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^e MRC EPIDEMIOLOGY UNIT   (United Kingdom)

^f UNIVERSITY OF LEUVEN   (Belgium)

^g KU LEUVEN DEPARTMENT OF REHABILITATION SCIENCES   (Belgium)

Author keywords

Association; Imprinting; Insulin like growth factor 2; Linkage; Type 2 diabetes

Indexed keywords

SOMATOMEDIN B; MICROSATELLITE DNA;

ADULT; AGE DISTRIBUTION; ALLELE; ARTICLE; BIRTH WEIGHT; BODY HEIGHT; CONTROLLED STUDY; DIZYGOTIC TWINS; DNA POLYMORPHISM; DYSLIPIDEMIA; FEMALE; GENE LOCATION; GENETIC ASSOCIATION; GENETIC LINKAGE; GENETIC RISK; GENOTYPE; HEALTH SURVEY; HUMAN; INHERITANCE; INSULIN SENSITIVITY; MAJOR CLINICAL STUDY; MALE; METABOLIC DISORDER; MICROSATELLITE MARKER; MONOZYGOTIC TWINS; MUTATIONAL ANALYSIS; NUCLEOTIDE SEQUENCE; OBESITY; PRIORITY JOURNAL; PROTEIN CONTENT; RISK ASSESSMENT; SINGLE NUCLEOTIDE POLYMORPHISM; BELGIUM; GENETIC PREDISPOSITION; GENETICS; METABOLIC DISEASES; METABOLISM; NEWBORN; PREGNANCY; RISK FACTOR; TWINS;

ADULT; BELGIUM; BIRTH WEIGHT; DISEASES IN TWINS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; INFANT, NEWBORN; INSULIN-LIKE GROWTH FACTOR II; LINKAGE (GENETICS); MALE; METABOLIC DISEASES; MICROSATELLITE REPEATS; POLYMORPHISM, SINGLE NUCLEOTIDE; PREGNANCY; RISK FACTORS; TWINS, MONOZYGOTIC; GENETIC LINKAGE;

EID: 70349101932     PISSN: 03070565     EISSN: 14765497     Source Type: Journal    
DOI: 10.1038/ijo.2009.126     Document Type: Article

References (53)

1. van Dijk MA, van Schaik FM, Bootsma HJ, Holthuizen P, Sussenbach JS. Initial characterization of the four promoters of the human insulin-like growth factor II gene. Mol Cell Endocrinol 1991; 81: 81-94.
2. Monk D, Sanches R, Arnaud P, Apostolidou S, Hills FA, Abu-Amero S et al. Imprinting of IGF2 P0 transcript and novel alternatively spliced INS-IGF2 isoforms show differences between mouse and human. Hum Mol Genet 2006; 15: 1259-1269.
3. Pham NV, Nguyen MT, Hu JF, Vu TH, Hoffman AR. Dissociation of IGF2 and H19 imprinting in human brain. Brain Res 1998; 810: 1-8.
4. Vu TH, Hoffman AR. Promoter-specific imprinting of the human insulin-like growth factor-II gene. Nature 1994; 371: 714-717.
5. Wu HK, Squire JA, Song Q, Weksberg R. Promoter-dependent tissue-specific expressive nature of imprinting gene, insulin-like growth factor II, in human tissues. Biochem Biophys Res Commun 1997; 233: 221-226. (Pubitemid 27215940)
6. DeChiara TM, Efstratiadis A, Robertson EJ. A growth-deficiency phenotype in heterozygous mice carrying an insulin-like growth factor II gene disrupted by targeting. Nature 1990; 345: 78-80.
7. Lau MM, Stewart CE, Liu Z, Bhatt H, Rotwein P, Stewart CL. Loss of the imprinted IGF2/cation-independent mannose 6-phosphate receptor results in fetal overgrowth and perinatal lethality. Genes Dev 1994; 8: 2953-2963.
8. Gicquel C, Le Bouc Y. Hormonal regulation of fetal growth. Horm Res 2006; 65 (Suppl 3): 28-33.
9. Gicquel C, Rossignol S, Cabrol S, Houang M, Steunou V, Barbu V et al. Epimutation of the telomeric imprinting center region on chromosome 11p15 in Silver-Russell syndrome. Nat Genet 2005; 37 : 1003-1007.
10. Delaval K, Wagschal A, Feil R. Epigenetic deregulation of imprinting in congenital diseases of aberrant growth. Bioessays 2006; 28: 453-459.
11. Weksberg R, Shuman C, Smith AC. Beckwith-Wiedemann syndrome. Am J Med Genet C Semin Med Genet 2005; 137: 12-23.
12. Rossetti L, Barzilai N, Chen W, Harris T, Yang D, Rogler CE. Hepatic overexpression of insulin-like growth factor-II in adulthood increases basal and insulin-stimulated glucose disposal in conscious mice. J Biol Chem 1996; 271: 203-208.
13. Rogler CE, Yang D, Rossetti L, Donohoe J, Alt E, Chang CJ et al. Altered body composition and increased frequency of diverse malignancies in insulin-like growth factor-II transgenic mice. J Biol Chem 1994; 269: 13779-13784.
14. Kadlecova M, Dobesova Z, Zicha J, Kunes J. Abnormal Igf2 gene in Prague hereditary hypertriglyceridemic rats: its relation to blood pressure and plasma lipids. Mol Cell Biochem 2008; 314: 37-43.
15. Van Laere AS, Nguyen M, Braunschweig M, Nezer C, Collette C, Moreau L et al. A regulatory mutation in IGF2 causes a major QTL effect on muscle growth in the pig. Nature 2003; 425: 832-836.
16. Sandhu MS, Gibson JM, Heald AH, Dunger DB, Wareham NJ. Low circulating IGF-II concentrations predict weight gain and obesity in humans. Diabetes 2003; 52: 1403-1408.
17. Heald AH, Kärvestedt L, Anderson SG, McLaughlin J, Knowles A, Wong L et al. Low insulin-like growth factor-II levels predict weight gain in normal weight subjects with type 2 diabetes. Am J Med 2006; 119: 167 e9-e15.
18. Barker DJ, Hales CN, Fall CH, Osmond C, Phipps K, Clark PM. Type 2 (non-insulin-dependent) diabetes mellitus, hypertension and hyperlipidaemia (syndrome X): relation to reduced fetal growth. Diabetologia 1993; 36: 62-67.
19. Hattersley AT, Tooke JE. The fetal insulin hypothesis: an alternative explanation of the association of low birthweight with diabetes and vascular disease. Lancet 1999; 353: 1789-1792.
20. O'Dell SD, Bujac SR, Miller GJ, Day IN. Associations of IGF2 ApaI RFLP and INS VNTR class I allele size with obesity. Eur J Hum Genet 1999; 7: 821-827.
21. O'Dell SD, Miller GJ, Cooper JA, Hindmarsh PC, Pringle PJ, Ford H et al. Apal polymorphism in insulin-like growth factor II (IGF2) gene and weight in middle-aged males. Int J Obes Relat Metab Disord 1997; 21: 822-825.
22. Bachner-Melman R, Zohar AH, Nemanov L, Heresco-Levy U, Gritsenko I, Ebstein RP. Association between the insulin-like growth factor 2 gene (IGF2) and scores on the Eating Attitudes Test in nonclinical subjects: a family-based study. Am J Psychiatry 2005; 162: 2256-2262.
23. Sayer AA, Syddall H, O'Dell SD, Chen XH, Briggs PJ, Briggs R et al. Polymorphism of the IGF2 gene, birth weight and grip strength in adult men. Age Ageing 2002; 31: 468-470.
24. Hart LM, Fritsche A, Rietveld I, Dekker JM, Nijpels G, Machicao F et al. Genetic factors and insulin secretion: gene variants in the IGF genes. Diabetes 2004; 53 (Suppl 1): S26-S30.
25. Gomes MV, Soares MR, Pasqualim-Neto A, Marcondes CR, Lo bo RB, Ramos ES. Association between birth weight, body mass index and IGF2/ApaI polymorphism. Growth Horm IGF Res 2005; 15 : 360-362.
26. Roth SM, Schrager MA, Metter EJ, Riechman SE, Fleg JL, Hurley BF et al. IGF2 genotype and obesity in men and women across the adult age span. Int J Obes Relat Metab Disord 2002; 26: 585-587.
27. Gaunt TR, Cooper JA, Miller GJ, Day IN, O'Dell SD. Positive associations between single nucleotide polymorphisms in the IGF2 gene region and body mass index in adult males. Hum Mol Genet 2001; 10: 1491-1501.
28. Heude B, Ong KK, Luben R, Wareham NJ, Sandhu MS. Study of association between common variation in the insulin-like growth factor 2 gene and indices of obesity and body size in middle-aged men and women. J Clin Endocrinol Metab 2007; 92: 2734-2738.
29. Kaku K, Osada H, Seki K, Sekiya S. Insulin-like growth factor 2 (IGF2) and IGF2 receptor gene variants are associated with fetal growth. Acta Paediatr 2007; 96: 363-367.
30. Loos R, Derom C, Vlietinck R, Derom R. The East Flanders Prospective Twin Survey (Belgium): a population-based register. Twin Res 1998; 1: 167-175.
31. Souren NY, Paulussen AD, Loos RJ, Gielen M, Beunen G, Fagard R et al. Anthropometry, carbohydrate and lipid metabolism in the East Flanders Prospective Twin Survey: heritabilities. Diabetologia 2007; 50: 2107-2116.
32. Abecasis GR, Cherny SS, Cookson WO, Cardon LR. MerlinFrapid analysis of dense genetic maps using sparse gene flow trees. Nat Genet 2002; 30: 97-101.
33. Barrett JC, Fry B, Maller J, Daly MJ. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 2005; 21: 263-265.
34. Neale MC, Boker SM, Xie G, Maes HH. Mx: Statistical Modeling, 6th edn, VCU Department of Psychiatry: Richmond, VA, 2002.
35. Souren NY, Zeegers MP, Janssen RG, Steyls A, Gielen M, Loos RJ et al. Anthropometry, Carbohydrate and Lipid Metabolism in the East Flanders Prospective Twin Survey: linkage of candidate genes using two sib-pair based variance components analyses. Twin Res Hum Genet 2008; 11: 505-516.
36. Lindsay RS, Kobes S, Knowler WC, Hanson RL. Genome-wide linkage analysis assessing parent-of-origin effects in the inheritance of birth weight. Hum Genet 2002; 110: 503-509.
37. Akaike H. A new look at the statistical model identification. IEEE Trans Automat Contr 1974; 19: 716-723.
38. Laird NM, Horvath S, Xu X. Implementing a unified approach to family-based tests of association. Genet Epidemiol 2000; 19 (Suppl 1): S36-S42.
39. Horvath S, Xu X, Laird NM. The family based association test method: strategies for studying general genotypeFphenotype associations. Eur J Hum Genet 2001; 9: 301-306.
40. Janssen JA, Lamberts SW. The role of IGF-I in the development of cardiovascular disease in type 2 diabetes mellitus: is prevention possible? Eur J Endocrinol 2002; 146: 467-477.
41. Mohan S, Baylink DJ. IGF-binding proteins are multifunctional and act via IGF-dependent and -independent mechanisms. J Endocrinol 2002; 175: 19-31.
42. Conover CA, Lee PD, Kanaley JA, Clarkson JT, Jensen MD. Insulin regulation of insulin-like growth factor binding protein-1 in obese and nonobese humans. J Clin Endocrinol Metab 1992; 74: 1355-1360.
43. Lee PD, Giudice LC, Conover CA, Powell DR. Insulin-like growth factor binding protein-1: recent findings and new directions. Proc Soc Exp Biol Med 1997; 216: 319-357.
44. Heald A, Stephens R, Gibson JM. The insulin-like growth factor system and diabetesFan overview. Diabet Med 2006; 23 (Suppl 1): 19-24.
45. Lewitt MS, Hilding A, Ostenson CG, Efendic S, Brismar K, Hall K. Insulin-like growth factor-binding protein-1 in the prediction and development of type 2 diabetes in middle-aged Swedish men. Diabetologia 2008; 51: 1135-1145.
46. Heald AH, Cruickshank JK, Riste LK, Cade JE, Anderson S, Greenhalgh A et al. Close relation of fasting insulin-like growth factor binding protein-1 (IGFBP-1) with glucose tolerance and cardiovascular risk in two populations. Diabetologia 2001; 44: 333-339.
47. Wallander M, Norhammar A, Malmberg K, Ohrvik J, Rydén L, Brismar K. IGF binding protein 1 predicts cardiovascular morbidity and mortality in patients with acute myocardial infarction and type 2 diabetes. Diabetes Care 2007; 30: 2343-2348.
48. Lee PD, Suwanichkul A, DePaolis LA, Snuggs MB, Morris SL, Powell DR. Insulin-like growth factor (IGF) suppression of IGFBP-1 production: evidence for mediation by the type I IGF receptor. Regul Pept 1993; 48: 199-206.
49. Caro JF, Poulos J, Ittoop O, Pories WJ, Flickinger EG, Sinha MK. Insulin-like growth factor I binding in hepatocytes from human liver, human hepatoma, and normal, regenerating, and fetal rat liver. J Clin Invest 1988; 81: 976-981.
50. Chao W, D'Amore PA. IGF2: epigenetic regulation and role in development and disease. Cytokine Growth Factor Rev 2008; 19: 111-120.
51. Caro JF, Ittoop O, Pories WJ, Meelheim D, Flickinger EG, Thomas F et al. Studies on the mechanism of insulin resistance in the liver from humans with noninsulin-dependent diabetes. Insulin action and binding in isolated hepatocytes, insulin receptor structure, and kinase activity. J Clin Invest 1986; 78: 249-258.
52. Li X, Cui H, Sandstedt B, Nordlinder H, Larsson E, Ekström TJ. Expression levels of the insulin-like growth factor-II gene (IGF2) in the human liver: developmental relationships of the four promoters. J Endocrinol 1996; 149: 117-124. (Pubitemid 26132836)
53. Rodriguez S, Gaunt TR, Day IN. Molecular genetics of human growth hormone, insulin-like growth factors and their pathways in common disease. Hum Genet 2007; 122: 1-21.